Cargando…
The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic facto...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387074/ https://www.ncbi.nlm.nih.gov/pubmed/32754412 http://dx.doi.org/10.7759/cureus.8878 |
_version_ | 1783564070530580480 |
---|---|
author | Evcimik, Taner Degerli, Mahmut Said Bilgic, Tayfun |
author_facet | Evcimik, Taner Degerli, Mahmut Said Bilgic, Tayfun |
author_sort | Evcimik, Taner |
collection | PubMed |
description | Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic factors and many studies have begun. The aim of this study is to evaluate breast cancer patients and to investigate other factors affecting breast cancer. Materials and methods Patients with breast cancer who were operated in our clinic between January 2005 and June 2007 were included in the study. Demographic characteristics, tumor size, lymph node involvement, grade, histological type, the status of estrogen and progesterone receptors (ER and PR), type of surgery performed, and cerb-B2 receptor status were recorded retrospectively. Results The mortality rate of the ER (+) PR (+) group was significantly lower than that of the ER (-) PR (-) group (p<0.05). There was no statistically significant difference between the ER (+) PR (+) cases and the mortality rates of any positive cases (p>0.05). There was a statistically significant difference between survival rates according to cerb-B2 status (p<0.01); cerb-B2 was positive in all patients who died. In cerb-B2 positive cases, there was a statistically significant difference between survival rates according to the tumor stages (p <0.05). Conclusion As a result; preoperative and postoperative staging of all breast cancer patients who applied to surgery clinics should be performed. Prognostic factors should be determined and patients should be directed to post-surgical treatment according to this information. Axillary lymph involvement, number, tumor size, estrogen receptor, progesterone receptor, and cerb-B2 status are safe markers that can be used to determine prognosis in our series. |
format | Online Article Text |
id | pubmed-7387074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-73870742020-08-03 The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer Evcimik, Taner Degerli, Mahmut Said Bilgic, Tayfun Cureus Pathology Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic factors and many studies have begun. The aim of this study is to evaluate breast cancer patients and to investigate other factors affecting breast cancer. Materials and methods Patients with breast cancer who were operated in our clinic between January 2005 and June 2007 were included in the study. Demographic characteristics, tumor size, lymph node involvement, grade, histological type, the status of estrogen and progesterone receptors (ER and PR), type of surgery performed, and cerb-B2 receptor status were recorded retrospectively. Results The mortality rate of the ER (+) PR (+) group was significantly lower than that of the ER (-) PR (-) group (p<0.05). There was no statistically significant difference between the ER (+) PR (+) cases and the mortality rates of any positive cases (p>0.05). There was a statistically significant difference between survival rates according to cerb-B2 status (p<0.01); cerb-B2 was positive in all patients who died. In cerb-B2 positive cases, there was a statistically significant difference between survival rates according to the tumor stages (p <0.05). Conclusion As a result; preoperative and postoperative staging of all breast cancer patients who applied to surgery clinics should be performed. Prognostic factors should be determined and patients should be directed to post-surgical treatment according to this information. Axillary lymph involvement, number, tumor size, estrogen receptor, progesterone receptor, and cerb-B2 status are safe markers that can be used to determine prognosis in our series. Cureus 2020-06-28 /pmc/articles/PMC7387074/ /pubmed/32754412 http://dx.doi.org/10.7759/cureus.8878 Text en Copyright © 2020, Evcimik et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pathology Evcimik, Taner Degerli, Mahmut Said Bilgic, Tayfun The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer |
title | The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer |
title_full | The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer |
title_fullStr | The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer |
title_full_unstemmed | The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer |
title_short | The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer |
title_sort | effect of prognostic factors on long-term protection in breast cancer |
topic | Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387074/ https://www.ncbi.nlm.nih.gov/pubmed/32754412 http://dx.doi.org/10.7759/cureus.8878 |
work_keys_str_mv | AT evcimiktaner theeffectofprognosticfactorsonlongtermprotectioninbreastcancer AT degerlimahmutsaid theeffectofprognosticfactorsonlongtermprotectioninbreastcancer AT bilgictayfun theeffectofprognosticfactorsonlongtermprotectioninbreastcancer AT evcimiktaner effectofprognosticfactorsonlongtermprotectioninbreastcancer AT degerlimahmutsaid effectofprognosticfactorsonlongtermprotectioninbreastcancer AT bilgictayfun effectofprognosticfactorsonlongtermprotectioninbreastcancer |